Engineered exosome nanovesicles for delivery of antibodies to treat inflammatory bowel disease

Journal:

Nature Communications

Published:

2026-02-13

DOI:

10.1038/s41467-026-69382-4

Affiliations:

3

Authors:

16

Go to article

Institutions	Authors	Share
State Key Laboratory of Advanced Medical Materials and Devices, China	15.000000 15.000000	0.94
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, China	0.500000	0.03
University of Chinese Academy of Sciences (UCAS), China	0.500000	0.03

Interested in Pharmacology and Pharmaceutical Sciences?